Mounjaro When Will Weight Loss

"There seem to be many people around me who have lost weight, so why am I the only one staying the same?" This is the question those who have started Mounjaro (active ingredient tirzepatide) most often bring up in the clinic. After 2 to 3 weeks of starting, impatience sets in, and quite a few are disappointed after expecting noticeable loss within a month. But this drug was not originally designed to make weight drop sharply from the first week. It has a structure in which change accumulates over several months as the dose is raised in stages, and understanding that incremental schedule and the timing of onset is the fastest way to reduce unnecessary impatience.

Mounjaro does not use the effective dose from the start but begins at the lowest dose and raises it in stages. Looking at the clinical trial design, the starting dose is 2.5 mg once a week, and this dose is closer to an introductory dose that helps the body adapt to the drug than a dose aimed at a weight-loss goal. This is because using a high dose from the start tends to bring on gastrointestinal reactions such as nausea, retching, and indigestion strongly.

So saying "I took 2.5 mg but there's no change after a month" may in fact mean that you have not even entered the stage to expect an effect yet. In the clinic, the most regrettable are those who interpret this section as "the drug isn't working" and stop on their own. The introductory dose is a preparation stage for full-fledged loss, and if you are troubled by poor appetite control, it is better to calmly check, starting from a medical approach to difficulty with appetite control.

It is standard to raise the dose by one step at 4-week intervals. In large-scale clinical studies, it was designed to start at 2.5 mg and increase by 2.5 mg every 4 weeks, reaching maintenance doses such as 5 mg, 10 mg, and 15 mg in stages. There is a reason for this 4-week interval. It is to secure time for the body to adapt after raising one step, to gauge how much the side effects are, and to judge whether to go to the next step.

Organizing the escalation process as a table:

The key here is that just reaching the maintenance dose usually takes 4 to 5 months. The desire to raise it quickly is understandable, but there is insufficient evidence that shortening the interval improves the effect, and rather it is reported to only increase gastrointestinal side effects. If you have just started this drug, it helps to understand the overall flow of diet injections in advance.

Felt change does not come all at once but accumulates gradually. As noted in the original article too, in many cases it takes several weeks after starting administration before changes in appetite and meal amount begin to be felt little by little, and the change in weight itself follows even later. In the first month, which is almost entirely the introductory dose section, it is rather natural for there to be no big change in the number on the scale.

What is important is that the timing of change differs from person to person. Some feel appetite suppression quickly even at the introductory dose, and some feel it only when close to the maintenance dose. So judging the drug's effect by the single criterion "no change after a month" is too early an assessment. If change feels slow, rather than judging alone, it is good to check the dose stage and the state of diet and exercise together in care.

The biggest change appears not in a short period but as accumulation over several months. In the large-scale clinical study over 72 weeks (about a year and a half) (SURMOUNT-1, 2022), meaningful weight loss was reported in participants who raised tirzepatide to the maintenance dose and used it steadily, and the higher the dose, the larger the average extent of loss. That said, these figures are the average of a clinical environment with concurrent diet and exercise management, and there may be individual variation.

The point at which weight reaches a "plateau," where it no longer changes greatly from a certain level, also differs from person to person, reported in the same study to be distributed in the section after roughly several months. In summary, the flow of onset is as follows.

• Early few weeks: introductory dose section, appetite change begins gradually
• Over several months: weight change accumulates as the dose is raised
• After that: the extent of change becomes gentle and approaches a plateau

In other words, "it drops in a month" is not it; "it accumulates over several months" is this drug's original timetable. If you are curious about the difference in the action and effect timetable with Wegovy, I recommend reading the difference between Wegovy and Mounjaro together.

The individual variation in onset timing and the extent of loss is less a problem of the drug than the result of several variables overlapping. Organizing the factors noted in the original article medically:

• Lifestyle patterns such as eating habits, meal amount, and protein intake
• Amount of exercise, muscle mass, and basal metabolic state
• Quality of sleep and stress level
• Whether there are comorbidities (diabetes, thyroid dysfunction, etc.)
• Individual responsiveness to the drug and the dose stage reached

In particular, for women, there are times when hormonal changes affect weight. Weight gain around the climacteric is often interlocked with hormonal environment changes rather than a matter of willpower, so it needs to be looked at together from the perspective that menopausal weight gain is due to hormones, not willpower. Considering even such backgrounds, it becomes clear why simply comparing your speed with the person next to you is meaningless.

The slow escalation schedule itself is a device to reduce side effects. The most commonly reported reactions are gastrointestinal symptoms such as nausea, retching, indigestion, and constipation, which usually stand out right after raising the dose and tend to subside as you adapt. So not rushing the increase is rather the way to continue comfortably. For more detail, you can refer to the side effects of diet injections guidance.

Another frequently received question is the rebound after stopping. Since stopping the drug also makes the appetite-suppressing effect disappear, it is reported that suddenly stopping in a state where lifestyle habits are not established can make weight increase again. This part is further covered in the rebound phenomenon after stopping. Cost is explained after consultation, and if you have comorbidities or medications you take, confirmation in care before starting is essential.

In the end, this drug's timetable is a matter of "how sustainably," not "how fast." Rather than being impatient that there is no change in the first month, you need a perspective that understands the dose escalation stage, manages diet, exercise, and sleep together, and looks ahead several months. To borrow the original article's expression, weight lost in an unsustainable way comes back and can even make a body that gains more easily. Going healthily, slowly, and together is in the end the fastest way.

Written by Lee Dong-hee, Director · OB-GYN specialist · See physician profile

First published September 15, 2025 · Last reviewed May 30, 2026

References: New England Journal of Medicine, SURMOUNT-1 (2022), Diabetes Obesity and Metabolism, Time to weight plateau (2025)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.